Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Cytomegalovirus Envelope Glycoprotein B market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Cytomegalovirus Envelope Glycoprotein Bmarket, defines the market attractiveness level of Human Cytomegalovirus Envelope Glycoprotein B market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Cytomegalovirus Envelope Glycoprotein B industry, describes the types of Human Cytomegalovirus Envelope Glycoprotein B market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Cytomegalovirus Envelope Glycoprotein B market and the development prospects and opportunities of Human Cytomegalovirus Envelope Glycoprotein B industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Cytomegalovirus Envelope Glycoprotein B market in Chapter 13.
By Player:
Trellis Bioscience, Inc
Astellas Pharma Inc
Vical Incorporated
VBI Vaccine Inc
Vakzine Projekt Management GmbH
By Type:
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
By End-User:
Infectious Disease
Oncology
Women's Health
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Cytomegalovirus Envelope Glycoprotein B Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Cytomegalovirus Envelope Glycoprotein B Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Cytomegalovirus Envelope Glycoprotein B Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Cytomegalovirus Envelope Glycoprotein B Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Cytomegalovirus Envelope Glycoprotein B Market Analysis and Outlook to 2022
-
7.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.2 United States Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.4 China Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.5 Japan Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.6 India Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
-
7.7 South Korea Human Cytomegalovirus Envelope Glycoprotein B Consumption (2017-2022)
8 Region and Country-wise Human Cytomegalovirus Envelope Glycoprotein B Market Analysis and Outlook to 2028
-
8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.2 United States Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.4 China Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.5 Japan Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.6 India Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
-
8.7 South Korea Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast (2022-2028)
9 Global Human Cytomegalovirus Envelope Glycoprotein B Market Outlook by Types and Applications to 2022
-
9.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CSJ-148 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CyMVectin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TRL-345 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global PPCM Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Cytomegalovirus Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Women's Health Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Human Cytomegalovirus Envelope Glycoprotein B Market Outlook by Types and Applications to 2028
-
10.1 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CSJ-148 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CyMVectin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TRL-345 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global PPCM Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Cytomegalovirus Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Women's Health Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Cytomegalovirus Envelope Glycoprotein B Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Cytomegalovirus Envelope Glycoprotein B Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Cytomegalovirus Envelope Glycoprotein B Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Cytomegalovirus Envelope Glycoprotein B Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Analysis
-
14.1 Trellis Bioscience, Inc
-
14.1.1 Trellis Bioscience, Inc Company Details
-
14.1.2 Trellis Bioscience, Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Trellis Bioscience, Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
14.2 Astellas Pharma Inc
-
14.2.1 Astellas Pharma Inc Company Details
-
14.2.2 Astellas Pharma Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharma Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
14.3 Vical Incorporated
-
14.3.1 Vical Incorporated Company Details
-
14.3.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
14.4 VBI Vaccine Inc
-
14.4.1 VBI Vaccine Inc Company Details
-
14.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
14.5 Vakzine Projekt Management GmbH
-
14.5.1 Vakzine Projekt Management GmbH Company Details
-
14.5.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Cytomegalovirus Envelope Glycoprotein B
-
Figure Human Cytomegalovirus Envelope Glycoprotein B Picture
-
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Country (2017-2022)
-
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Figure China Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Figure India Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Cytomegalovirus Envelope Glycoprotein B Consumption and Growth Rate (2017-2022)
-
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast by Country (2022-2028)
-
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Cytomegalovirus Envelope Glycoprotein B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CSJ-148 Consumption and Growth Rate (2017-2022)
-
Figure Global CyMVectin Consumption and Growth Rate (2017-2022)
-
Figure Global TRL-345 Consumption and Growth Rate (2017-2022)
-
Figure Global PPCM Consumption and Growth Rate (2017-2022)
-
Figure Global Cytomegalovirus Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Women's Health Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CSJ-148 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CyMVectin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TRL-345 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PPCM Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytomegalovirus Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Women's Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Cytomegalovirus Envelope Glycoprotein B Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Cytomegalovirus Envelope Glycoprotein B Export by Region (Top 5 Countries) (2017-2028)
-
Table Trellis Bioscience, Inc (Foundation Year, Company Profile and etc.)
-
Table Trellis Bioscience, Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trellis Bioscience, Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
Table Vical Incorporated (Foundation Year, Company Profile and etc.)
-
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
Table VBI Vaccine Inc (Foundation Year, Company Profile and etc.)
-
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
Table Vakzine Projekt Management GmbH (Foundation Year, Company Profile and etc.)
-
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product and Service
-
